Literature DB >> 11872249

Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells.

Wakako Maruyama1, Tomoko Oya-Ito, Masayo Shamoto-Nagai, Toshihiko Osawa, Makoto Naoi.   

Abstract

6-Hydroxydopamine is a neurotoxin specific to dopamine neurons, and this neurotoxin at 20 muM was confirmed to induce mainly apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. During the apoptotic process, translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) into nuclei was observed, which is now proposed as an apoptogenic signal in various types of apoptosis. However, it remains to be clarified, how GAPDH is translocated into nuclei. In this paper, GAPDH translocation was followed by fluoro- and electron-microscopic observation using antibody against GAPDH. Before the nuclear translocation, a condensed mass of GAPDH protein was detected in the Golgi apparatus, which was identified by 6-([N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]hexanoyl)-sphingosine, a selective marker of Golgi apparatus. These results suggest that the Golgi apparatus may be involved in the compartmentalization of GAPDH from cytosol to nuclei.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872249     DOI: 10.1016/s0304-3940(01)02490-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  The diverse functions of GAPDH: views from different subcellular compartments.

Authors:  Carlos Tristan; Neelam Shahani; Thomas W Sedlak; Akira Sawa
Journal:  Cell Signal       Date:  2010-08-19       Impact factor: 4.315

2.  Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.

Authors:  Elizabeth A Sabens Liedhegner; Kelly M Steller; John J Mieyal
Journal:  Chem Res Toxicol       Date:  2011-08-22       Impact factor: 3.739

Review 3.  Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Biochim Biophys Acta       Date:  2011-07-23

Review 4.  Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration.

Authors:  D Allan Butterfield; Sarita S Hardas; Miranda L Bader Lange
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.

Authors:  Mark D Berry
Journal:  J Psychiatry Neurosci       Date:  2004-09       Impact factor: 6.186

6.  Expression of sphingosine kinase gene in the interactions between human gastric carcinoma cell and vascular endothelial cell.

Authors:  Juan Ren; Lei Dong; Cang-Bao Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation.

Authors:  Neil A Demarse; Suriyan Ponnusamy; Eleanor K Spicer; Elif Apohan; John E Baatz; Besim Ogretmen; Christopher Davies
Journal:  J Mol Biol       Date:  2009-10-02       Impact factor: 5.469

Review 8.  GAPDH in neuroblastoma: Functions in metabolism and survival.

Authors:  Kevin Cornett; Anna Puderbaugh; Olivia Back; Rolf Craven
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

9.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interaction with 3' ends of Japanese encephalitis virus RNA and colocalization with the viral NS5 protein.

Authors:  Shang-Hua Yang; Mei-Lan Liu; Chih-Feng Tien; Shih-Jie Chou; Ruey-Yi Chang
Journal:  J Biomed Sci       Date:  2009-04-15       Impact factor: 8.410

10.  Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population.

Authors:  Ling Liu; Nian Xiong; Ping Zhang; Chunnuan Chen; Jinsha Huang; Guoxin Zhang; Xiaoyun Xu; Yan Shen; Zhicheng Lin; Tao Wang
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.